The Inflation Reduction Act: What Drugmakers Should Know
The Inflation Reduction Act is one of the Biden administration’s signature pieces of legislation, and its drug pricing provisions should really deliver significant improvements to America’s pharmaceutical marketplace. New policies…
Insulin’s high cost goes beyond drugmakers to industry’s price mediators
Eli Lilly & Co.’s announcement that it is slashing prices for its major insulin products could make life easier for some diabetes patients while easing pressure on Big Pharma. It…